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Abstract
Background: Necrotizing enterocolitis (NEC) is a severe multifactorial disease in preterm neonates associated
with high morbidity and mortality. Better insight into prognostic values of the many reported factors associated
with NEC is needed to enable identification of neonates at risk for NEC. The aim was to systematically review the
literature to identify independent risk factors for NEC from the literature.
Methods: Medline, Cochrane, Embase, Pubmed and Google Scholar were searched systematically for cohort studies
reporting prognostic factors for NEC in neonates using multivariable analysis. Studies were scored with the Quality
In Prognosis Studies tool (QUIPS).
Results: From 5154 initial hits, 14 prognostic studies were included, with various designs. Study quality was rated
high in three studies, moderate or low in the 11 others. Significant prognostic factors for NEC reported in at least
two studies were: low birth weight, small for gestational age, low gestational age, assisted ventilation, premature
rupture of membranes, black ethnicity, sepsis, outborn, hypotension (all increased risk), surfactant therapy (conflicting
results) and cesarean section (lower risk). Meta-analysis was considered not feasible.
Conclusion: High quality studies on prognostic factors for NEC are rare. Several prognostic factors, that are not
necessarily causal, are associated with NEC. High quality prognostic research is necessary to establish the predictive
values of these factors.
Keywords: necrotizing enterocolitis, intestinal perforation, preterm, neonatal intensive care unit, risk factors, prognosis,
epidemiology
Background
Necrotizing enterocolitis (NEC) is one of the most se-
vere complications of preterm birth occurring in 5–10%
of very low birth weight infants [1, 2]. Although more
and more (extremely) preterm infants survive, the num-
ber of deaths attributed to NEC has been increasing [3].
Mortality rates ranging from 15% to 30% have been re-
ported [4]. Surgical treatment is often needed, and survi-
vors are at increased risk for poor long-term growth and
neurodevelopmental impairment [5]. Despite preventive
strategies such as prenatal glucocorticoid administration,
breast feeding, use of donor milk and probiotic supple-
mentation, NEC is still relatively common in most neo-
natal intensive care units (NICUs) [6–10].
NEC is difficult to predict in individual cases. The
etiology is complex and multifactorial, including genetic
predisposition, intestinal immaturity, imbalance in micro-
vascular tone, abnormal microbial colonization and highly
immune-reactive intestinal mucosa [1]. A common
inflammatory pathway leads to intestinal ischemia, pneu-
matosis, necrosis and eventually perforation [11].
Many observational studies have reported clinical and
non-clinical risk factors associated with NEC, but the
prognostic value usually is unclear. Most of these studies
were not designed to answer prognostic questions prop-
erly [12]. To identify independent risk factors for a
complex disease as NEC, a (preferably prospective) prog-
nostic cohort design with multivariable analysis includ-
ing multiple co-variates is considered most appropriate
[12–14]. The aim of this study was to provide a
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systematic review of the literature on prognostic studies
reporting on independent risk factors for NEC in
neonates.
Methods
Study selection
This systematic review was guided by the PRISMA
Statement, a 27 item checklist to improve the reporting
of systematic reviews [15]. A search strategy was devel-
oped in collaboration with a clinical librarian to search
PubMed, Embase, Medline, Web-of-science, Cochrane
and Google Scholar. An initial search was conducted in
January 2014 and updated in August 2016, using terms
related to necrotizing enterocolitis, intestinal perforation,
neonates, birth weight, gestation, prediction, prognosis,
epidemiology and risk factors. The complete search strat-
egy is reported as supplemental material (Additional file 1).
References of included studies were checked for additional
eligible studies.
 Studies were included for analysis if satisfying
all following criteria: (1) full English written
publications, (2) with a prospective or retrospective
cohort study or nested case-control design (3)
identifying (neonatal or non-neonatal) prognostic
factors for NEC (primary or secondary outcome),
(4) using multivariable data analysis including
more than 2 co-variates, (5) in a study population
of neonates/newborns, preterm infants, very low
birth weight (VLBW) or extremely low birth
weight (ELBW) infants. No explicit use of the
term prognostic was required for inclusion.
 Excluded were studies (1) only reporting on
associative models of one or two variables with
NEC (also if adjustment for potential confounders
was performed), or (2) focusing only on risk factors
for other abdominal problems than NEC such as
spontaneous focal intestinal perforation, viral
enteritis and allergic colitis.
After duplicates had been removed, two independent
reviewers (NS, RG) screened titles and abstracts on both
inclusion and exclusion criteria. Articles identified as
potentially eligible underwent a full text review. Any dis-
agreements between the two reviewers concerning study
selection, quality assessment and interpretation of
results were discussed and resolved in consensus meet-
ings with all authors.
Quality assessment
The methodological quality of full text reports was inde-
pendently assessed by the same researchers using the
Quality In Prognosis Studies (QUIPS) tool [16]. The
QUIPS tool assesses risk of bias in prognostic studies by
rating each individual article in six domains: study par-
ticipation, study attrition, measurement of prognostic
factors, measurement of outcomes, measurement of
confounding, and statistical analysis and reporting. As
prognostic studies are designed to predict a specific out-
come based on a combination of possible prognostic fac-
tors of equal interest, the domain of confounding was
considered irrelevant. Therefore, an adapted QUIPS
without items addressing confounding was used [17]. As
NEC was assumed to be a short-term outcome in the in-
cluded studies, items on long-term follow-up in the
quality assessment were not included.
Quality points for a total of 17 items in five domains
were assigned to each study, adding up to a total score
of 75 points maximum. Domain items were scored as
high when sufficient information concerning the risk of
bias was present and the estimated risk of bias was con-
sidered low. Items were scored as moderate when the
article provided insufficient information about this do-
main and low quality when an item was not reported or
was not reported clearly or the estimated risk of bias
was considered high. The quality of the studies was
ranked high if ≥60 points (≥80% of the maximum score);
moderate if 45–59 points (≥60% and <80% of the max-
imum score); and low if <45 points (<60% of maximum
score) were given as described previously [17].
Data extraction and reporting
A standardized form was used to guide and document
data extraction systematically. The following data were
extracted: study characteristics (publication characteris-
tics, study design, method of analysis, number of sub-
jects, type and number of prognostic factors, outcomes
of interest); patient characteristics (gestational age, birth
weight, gender); and strength of association (relative
risks (RR) and odds ratios (OR)). To restrict the data to
those of most clinical interest, we only present details on
statistically significant prognostic factors (p < 0.05) that
were reported in at least two studies.
Results
Search and inclusion
The literature search yielded a total of 11,335 studies
(Fig. 1). After removing duplicates 5154 articles
remained of which titles and abstracts were screened.
Full texts of 78 articles were retrieved after assessment
for eligibility. A total of 14 articles met the selection
criteria and were included in the study. No additional
eligible studies were identified through bibliographic
review of the included studies.
Study characteristics
The quality assessment results are listed in Table 1.
Three of the included studies were of high quality, 11
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were of moderate quality and none of low quality.
Details of the included studies are presented in Table 2.
Definitions of study population and outcome varied. Ten
studies had a retrospective study design and four studies
a prospective study design. In seven studies the study
population consisted of VLBW infants, defined by birth
weight below 1500 g. One study included neonates with
intrauterine growth retardation (IUGR) and two studies
neonates admitted to the NICU. In four studies the
population was defined by gestational age: below
33 weeks, 23–34, 23–32 and 23–36 weeks. The outcome
measure was often not clearly described and included
NEC Bell stages I and II in one study, and stages II and
III in all others.
Prognostic factors
The 14 included studies described 43 statistically signifi-
cant risk factors for NEC identified by multivariable ana-
lysis. Eleven of these factors were significantly associated
with NEC in at least two studies (Table 3). None of the
Fig. 1 Flow chart of the systematic literature search
Table 1 Results of quality assessment of studies on NEC related prognostic factors according to the QUIPS tool [17]
Study Study participation
(max. 15)
Study attrition
(max. 15)
Prognostic factor
measurement
(max. 15)
Outcome measurement
(max. 15)
Statistical analysis
and reporting
(max. 15)
Quality score
(max. 75)
Gephart et al. (2014) [18] 15 5 12.5 15 15 62.5
Lee et al. (2016) [38] 15 5 12.5 12.5 15 60
Youn et al. (2015) [30] 15 5 12.5 12.5 15 60
Boo et al. (2012) [21] 15 5 12.5 10 15 57.5
Drenckpohl et al. (2010) [36] 15 5 10 12.5 15 57.5
Guthrie et al. (2003) [23] 15 5 10 12.5 15 57.5
Yee et al. (2012) [27] 15 5 12.5 10 15 57.5
Gagliardi et al. (2008) [28] 15 5 12.5 7.5 15 55
Manogura et al. (2008) [39] 15 5 10 10 15 55
Yamoto et al. (2016) [26] 15 5 10 10 15 55
Faustini et al. (2003) [37] 13.5 5 10 12.5 12.5 53.5
Carter et al. (2008) [22] 15 5 10 10 12.5 52.5
Luig et al. (2004) [25] 15 5 10 7.5 15 52.5
Uauy et al. (1991) [24] 12 5 10 10 12.5 49.5
NEC necrotizing enterocolitis, QUIPS quality in prognosis studies
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prognostic factors were assessed in all studies. Of the 11
reproducible factors, the following were associated with
an increased risk of NEC: small for gestational age, low
gestational age, assisted ventilation, sepsis, hypotension,
PROM, black ethnicity and outborn status (Table 4).
The factor low birth weight was associated differently
with NEC in 5 studies. The association with surfactant
therapy also showed contrasting directions. Birth by
cesarean section was associated with a decreased risk of
NEC.
Because of the diversity in study population, definition
and incidence of outcome and type of analysis, the mea-
sures of associations need to be interpreted in the con-
text of the study characteristics as reported in Table 2.
Because of substantial heterogeneity in design, popula-
tion, prognostic factors and outcomes of the included
prognostic studies, it was not feasible to perform a
meta-analysis.
Discussion
This is the first systematic review of prognostic studies
on risk factors for NEC in neonates. Only three of the
14 included studies scored high for methodological qual-
ity; all others scored moderate. This was mostly because
of limited information on definition and measurement
of the prognostic factor and on the outcome of NEC.
Only one report was found on the development of a pre-
diction model for the outcome of NEC [18].
We defined a prognostic study design based on several
specific criteria suggested in the literature. Aiming to
estimate the risk of developing a future clinical outcome
(NEC) based on more than one (independent) character-
istic, is considered the key feature of a prognostic study
design [12–14]. Therefore we only included studies with
a defined study population and multivariable analysis of
variables of potential equal importance. We did not
include trials or studies that focused on the association
between NEC and a single risk factor. Although these
studies may generate relevant hypotheses, these do not
address prognostic questions from a clear prognostic
research perspective [12].
Risk factors for NEC
Low birth weight is the most commonly reported signifi-
cant prognostic factor for NEC among neonates in the
current literature, which is in line with large cohort
studies describing the highest incidence of NEC among
the infants with the lowest birth weights [19, 20]. Inter-
estingly, the clinical relevance of birth weight as an inde-
pendent prognostic factor for NEC is questionable with
odds ratios (ORs) ranging between 0.999–1.001 [21–24].
Presumably, low gestational age or being small for gesta-
tional age are clinically more important. However, asso-
ciations between NEC and these factors were only
confirmed by multivariable analysis in four and two of
the studies respectively [18, 25–27].
Also of interest, two studies showed a protective effect
of cesarean section for developing NEC (OR both 0.60)
[23, 24]. The authors suggest that this is due to less
stress during delivery, although they point out that selec-
tion bias may have occurred. Surfactant therapy proved
a positive predictor for NEC in one study but a negative
predictor in another [21, 28]. The authors of the latter
study explained this by improvement of pulmonary func-
tion leading to less gut ischemia. Boo et al. reported that
surfactant was administered only to infants with severe
respiratory distress syndrome (RDS), suggesting that not
surfactant but severe RDS was a significant risk factor
for NEC [21]. Kliegman et al. studied RDS and NEC and
concluded that neonatal hypoxia is not etiologically re-
lated to NEC [29]. They found that mild or no RDS was
associated with an increased risk of NEC in contrast to
severe RDS, however by performing only univariable
analysis. It is unclear whether this can be explained by a
protective effect of surfactant in the severe cases or by
other factors such as different nutritional or antibiotic
treatment. Assisted ventilation was also associated with
an increased risk of NEC [22, 23, 28]. The question
arises whether this reflects disease severity - as the sick-
est patients (with the highest risk for NEC) will need
ventilation - or the mechanical ventilation itself, as dis-
ease severity (other than by birth weight and gestation
age) was not adjusted for in all of these studies.
Gephart et al. were the only authors who described
the development of a prediction model. Their model
Table 3 Summary of significant prognostic factors for NEC by
high, moderate and low quality studies
Prognostic factor High quality Moderate quality Low quality
Birth weight 1× 4× -
Gestational age (weeks) 1× 3× -
Sepsis 1× 2× -
Ethnicity 1× 2× -
Hypotension 1× 1× -
Outborn 1× 1× -
Assisted ventilation - 3× -
Cesarean section - 2× -
PROM - 2× -
Small for gestational age - 2× -
Surfactant - 2× -
The table shows the statistically significant prognostic factors reported in at
least two studies. The quality of the studies was ranked high if ≥60 points
(≥80% of the maximum score), moderate if 45–59 points (≥60% and <80% of
the maximum score) and low if <45 points (<60% of maximum score) were
given. Using the QUIPS tool
NEC necrotizing enterocolitis, PDA patent ductus arteriosus, PROM premature
rupture of membranes, RDS respiratory distress syndrome, QUIPS quality in
prognosis studies
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(GutCheckNEC) included 10 clinical risk factors based on
a large neonatal dataset [18]. They found that hypotension
requiring inotropic treatment was associated with an in-
creased risk of NEC. Also, Youn et al. considered
hypotension within a week of life, as an independent risk
factor for NEC [30]. They suggest that the circulatory col-
lapse in the first week of life may assault the gastrointes-
tinal blood flow resulting in higher NEC incidence. Two
studies showed neonates who were born outside of the
hospital were at greater risk for developing NEC com-
pared to inborn neonates, which was also included in the
model of Gephart et al. [18, 27].
The only maternal or perinatal prognostic factors for
which evidence in the prognostic literature was found
were PROM, cesarean section and being inborn. Inter-
estingly, for commonly assumed clinical neonatal risk
factors for NEC such as umbilical lines, red cell transfu-
sions, H2 blockers, and (high osmolar) formula feeding
no prognostic evidence was found [20, 31–35]. These
factors showed no significant associations in prognostic
studies, or have only been reported in studies without a
prognostic design.
White ethnicity was associated with a lower risk for
NEC compared to black ethnicity in multivariable ana-
lyses [18, 24, 36]. However, one study could not confirm
these findings, probably due to the overwhelming effects
of other factors in the multivariable model [22]. Another
finding from two multivariable analyses is an association
between diagnosis and treatment of sepsis and NEC,
which was defined as blood culture proven late onset
sepsis in one study and undefined sepsis prior to NEC in
the other [28, 36].
Interpretation of results
When interpreting the results, the following consider-
ations should be taken into account. Firstly, most
included studies were of limited quality and hetero-
geneous. The incidence of NEC stages II-III varied
widely, probably due to differences in the selection
of the study population and in NEC classification
[18, 21–28, 30, 36–39].
Secondly, predictability is not synonymous to causality,
although this is often inferred. This is most striking in
studies that are unclear on or even ignore the temporal-
ity between exposure and onset of outcome. This was
nicely pointed out by Patel et al., who studied the associ-
ation between red blood cell (RBC) transfusions and
NEC. They showed that severe anemia but not red blood
cell (RBC) transfusion was associated with an increased
risk of NEC and suggested that prevention of anemia
may be more beneficial than minimizing RBC transfu-
sions [40].
Discriminating etiologic and prognostic study designs
is complex, especially because the methodological
approaches overlap to some extent. Prognostic research
focuses on the probability of a particular state of health
whereas etiological research aims to assess the causal re-
lationship between risk factors and outcome. Therefore
every causal factor is a predictor but not every predictor
is causally related to the outcome [12, 41].
Lastly, the problem of unreported negative findings
even within a published report is worth mentioning. Not
all studies described the total set of baseline variables in-
cluded in the multivariable model. Univariable signifi-
cant factors may have tested non-significant in
multivariable models and left out of the final model. By
not reporting non-significant factors, it remains impos-
sible to rule out factors that are often assumed to be
predictors for NEC. Also, the prognostic factors reported
in this review, may have been non-significant in other
reports.
Strengths and limitations
Strengths of this review are the broad search strategy,
the systematic rating of risk of bias using QUIPS and
reporting of data according to PRISMA. Dretzke’s key
points for the methodological approach for systematic
review of prognostic factors were followed [42].
Nevertheless, several limitations may have influenced
our study selection and results. Reliable identification of
prognostic studies can be difficult especially in case of
incomplete reporting and diversity of terminology [42].
Language bias may have occurred by excluding non-
English articles. Earlier reported but arbitrarily set cut-
off points for low, moderate and high quality in the
QUIPS rating were used. Prognostic factors studied once
were not summarized in this review but can also be rele-
vant predictors of NEC. This concerned, for example,
the only report on multivessel fetal Doppler imaging, by
Manogura et al., which still may be relevant [39].
Future perspectives
Well-designed prospective prognostic studies are needed
with detailed reporting on definitions, methods and
measurement of the prognostic factor and outcome.
Special attention should be given to timing of the expo-
sures in relation to the diagnosis of NEC. It would be in-
teresting not only to focus on patient factors but also on
maternal factors. Maternal lifestyle factors (such as
smoking and obesity), morbidity (such as diabetes, pre-
eclampsia, and chorioamnionitis) and prenatal medica-
tion (such as antibiotics and corticosteroids) may also be
relevant risk factors for NEC [43–48]. A second step is
the development and validation of a prediction model to
quantify individual risk profiles and identify patients at
risk. Until now this has only been performed by Gephart
et al. who developed a model based on a large set of
retrospective data. Their model still needs external
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validation in other neonatal populations to evaluate its
general clinical usefulness. In our opinion development
and validation of prospective prediction models are still
necessary for preventive strategies and future reduction
of the incidence of NEC.
Conclusion
It is concluded that high quality studies on prognostic
factors for NEC are rare. Several prognostic factors are
associated with NEC, of which not all are necessarily
causal. Ruling out factors is hampered by incomplete
reporting. Future high quality prognostic (and predictive)
research is necessary to enable clinicians to identify
patients at high risk for NEC.
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